SI3596080T1 - Farmakološko aktivni aliciklični-substituirani pirazolo-(1,5-a)pirimidinski derivati - Google Patents

Farmakološko aktivni aliciklični-substituirani pirazolo-(1,5-a)pirimidinski derivati

Info

Publication number
SI3596080T1
SI3596080T1 SI201830495T SI201830495T SI3596080T1 SI 3596080 T1 SI3596080 T1 SI 3596080T1 SI 201830495 T SI201830495 T SI 201830495T SI 201830495 T SI201830495 T SI 201830495T SI 3596080 T1 SI3596080 T1 SI 3596080T1
Authority
SI
Slovenia
Prior art keywords
pharmacologically active
pyrimidine derivatives
substituted pyrazolo
active alicyclic
alicyclic
Prior art date
Application number
SI201830495T
Other languages
English (en)
Slovenian (sl)
Inventor
Istvan Borza
Viktor Roman
Janos Eles
Zsuzsa Hadady
Original Assignee
Richter Gedeon Nyrt.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt., filed Critical Richter Gedeon Nyrt.,
Publication of SI3596080T1 publication Critical patent/SI3596080T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems
    • C07D491/147Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SI201830495T 2017-03-13 2018-03-12 Farmakološko aktivni aliciklični-substituirani pirazolo-(1,5-a)pirimidinski derivati SI3596080T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU1700108A HU231058B1 (hu) 2017-03-13 2017-03-13 Gyógyászatilag hatékony aliciklusos-szubsztituált pirazolo[1,5-a]pirimidin származékok
PCT/IB2018/051599 WO2018167630A1 (en) 2017-03-13 2018-03-12 PHARMACOLOGICALLY ACTIVE ALICYCLIC-SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES
EP18713016.6A EP3596080B1 (en) 2017-03-13 2018-03-12 Pharmacologically active alicyclic-substituted pyrazolo[1,5-a]pyrimidine derivatives

Publications (1)

Publication Number Publication Date
SI3596080T1 true SI3596080T1 (sl) 2022-01-31

Family

ID=89992389

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201830495T SI3596080T1 (sl) 2017-03-13 2018-03-12 Farmakološko aktivni aliciklični-substituirani pirazolo-(1,5-a)pirimidinski derivati

Country Status (32)

Country Link
US (1) US11026946B2 (https=)
EP (1) EP3596080B1 (https=)
JP (1) JP7153662B2 (https=)
KR (1) KR20190127779A (https=)
CN (1) CN110431142A (https=)
AR (1) AR111176A1 (https=)
AU (1) AU2018235266B2 (https=)
BR (1) BR112019018843A2 (https=)
CA (1) CA3056185A1 (https=)
CL (1) CL2019002601A1 (https=)
CO (1) CO2019010120A2 (https=)
CY (1) CY1124708T1 (https=)
DK (1) DK3596080T3 (https=)
EA (1) EA038756B1 (https=)
EC (1) ECSP19072975A (https=)
ES (1) ES2893824T3 (https=)
GE (1) GEP20217256B (https=)
HR (1) HRP20211850T1 (https=)
HU (2) HU231058B1 (https=)
IL (1) IL268923A (https=)
LT (1) LT3596080T (https=)
MX (1) MX2019011000A (https=)
MY (1) MY195262A (https=)
PE (1) PE20191646A1 (https=)
PH (1) PH12019501968A1 (https=)
PL (1) PL3596080T3 (https=)
PT (1) PT3596080T (https=)
RS (1) RS62533B1 (https=)
SG (1) SG11201907864YA (https=)
SI (1) SI3596080T1 (https=)
UA (1) UA124783C2 (https=)
WO (1) WO2018167630A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ797702A (en) 2017-03-13 2026-03-27 Lundbeck La Jolla Research Center Inc Dual magl and faah inhibitors
HU231057B1 (hu) 2017-03-13 2020-04-28 Richter Gedeon Nyrt Gyógyászatilag hatékony aril-szubsztituált pirazolo[1,5-a]pirimidin származékok
TWI901650B (zh) 2020-03-26 2025-10-21 匈牙利商羅特格登公司 啶及吡啶并〔3,4-c〕嗒衍生物
TWI907472B (zh) * 2020-08-05 2025-12-11 匈牙利商羅特格登公司 具藥理活性之經雜環取代的吡唑并〔1,5-a〕嘧啶衍生物
HU231691B1 (hu) 2021-09-29 2025-10-28 Richter Gedeon Nyrt GABAA ALFA5 receptor modulátor hatású biciklusos aminszármazékok
CN115872095A (zh) * 2022-11-28 2023-03-31 南通三鑫车灯配件有限公司 一种汽车车灯反光罩的生产线流转装置

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100802863B1 (ko) 2004-03-02 2008-02-12 에프. 호프만-라 로슈 아게 불안증, 우울증 및 간질의 치료를 위한 gaba 수용체리간드로서 4-(설파닐-피리미딘-4-일메틸)-모폴린 유도체및 관련 화합물
GB0512844D0 (en) 2005-06-23 2005-08-03 Novartis Ag Organic compounds
KR100753017B1 (ko) 2006-05-25 2007-08-30 한국화학연구원 7-(3,4-디알콕시페닐)-피라졸로[1,5-a]피리미딘 화합물을포함하는 관절염, 아토피 피부염, 백혈병을 포함한 암 및알쯔하이머, 우울증 또는 기억력 감소 등의 뇌질환의 치료및 예방을 위한 약제학적 조성물
EP2271646A1 (en) 2008-03-31 2011-01-12 Takeda Pharmaceutical Company Limited Apoptosis signal-regulating kinase 1 inhibitors
TWI648281B (zh) 2013-10-17 2019-01-21 日商安斯泰來製藥股份有限公司 含硫二環式化合物
EP3286192A1 (en) 2015-04-20 2018-02-28 AbbVie Deutschland GmbH & Co KG Substituted pyrazolopyrimidines and method of use
JP2018199623A (ja) * 2015-10-22 2018-12-20 大正製薬株式会社 含窒素縮合複素環化合物
HU231057B1 (hu) 2017-03-13 2020-04-28 Richter Gedeon Nyrt Gyógyászatilag hatékony aril-szubsztituált pirazolo[1,5-a]pirimidin származékok

Also Published As

Publication number Publication date
MY195262A (en) 2023-01-11
CY1124708T1 (el) 2022-07-22
EP3596080B1 (en) 2021-09-01
CO2019010120A2 (es) 2019-10-09
ES2893824T3 (es) 2022-02-10
ECSP19072975A (es) 2019-11-30
AU2018235266A1 (en) 2019-10-17
PL3596080T3 (pl) 2022-01-31
LT3596080T (lt) 2021-11-25
JP2020510041A (ja) 2020-04-02
HU231058B1 (hu) 2020-04-28
RS62533B1 (sr) 2021-11-30
PT3596080T (pt) 2021-10-22
BR112019018843A2 (pt) 2020-04-14
CA3056185A1 (en) 2018-09-20
EA038756B1 (ru) 2021-10-14
CN110431142A (zh) 2019-11-08
IL268923A (en) 2019-10-31
WO2018167630A1 (en) 2018-09-20
KR20190127779A (ko) 2019-11-13
MX2019011000A (es) 2019-10-17
UA124783C2 (uk) 2021-11-17
AU2018235266B2 (en) 2021-09-30
AR111176A1 (es) 2019-06-12
SG11201907864YA (en) 2019-09-27
HUE056562T2 (hu) 2022-02-28
DK3596080T3 (da) 2021-11-15
EA201992127A1 (ru) 2020-02-06
CL2019002601A1 (es) 2020-01-24
JP7153662B2 (ja) 2022-10-14
HUP1700108A2 (en) 2018-09-28
US20200129515A1 (en) 2020-04-30
EP3596080A1 (en) 2020-01-22
PE20191646A1 (es) 2019-11-07
US11026946B2 (en) 2021-06-08
PH12019501968A1 (en) 2020-06-29
GEP20217256B (en) 2021-05-25
HRP20211850T1 (hr) 2022-03-04

Similar Documents

Publication Publication Date Title
IL260923B (en) History of pyrazolo[5,1-a]pyrazin-4-yl as jak inhibitors
SI3596080T1 (sl) Farmakološko aktivni aliciklični-substituirani pirazolo-(1,5-a)pirimidinski derivati
IL266170A (en) A process for the preparation of pyrazolo[1,5-a]pyrimidines and their salts
IL266305B (en) History of [4,2,1]triazolo[5,1-a]pyrimidine as pde2 inhibitors
SI3305785T1 (sl) Derivat pirido(3,4-D)pirimidina in njegova farmacevtsko sprejemljiva sol
EP3268000A4 (en) Pyrazolo[1,5-a][1,3,5]triazine and pyrazolo[1,5-a]pyrimidine derivatives as cdk inhibitors
IL262673A (en) A pyrazolo[5,1-a]pyrimidine compound
ZA201902893B (en) Pyrido[3, 4-d]pyrimidine derivative and pharmaceutically acceptable salt thereof
IL290419A (en) Imidazo[a-1,5]pyrazine derivatives as inhibitors of pi3k delta
HUE056561T2 (hu) Gyógyászatilag hatékony aril-szubsztituált pirazolo[1,5-a]pirimidin származékok
IL272988A (en) Imidazo-[1,5-A]pyrazine derivatives as PI3K-delta inhibitors
EP3196199A4 (en) Substituted n-(pyrrolidine-3-yl)-7h-pyrrolo[2,3-d]pyrimidine-4-amine as janus kinase inhibitor
EP3618837A4 (en) MULTI-DIRECTIONAL NUCLEOSIDE DERIVATIVES
EP3903788A4 (en) PYRAZOLO[1,5-A] PYRIMIDINE MACROCYCLIC COMPOUND
HUE052997T2 (hu) JAK kináz inhibitor pirazol[1,5-a]pirimidin származékok